{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:08:07Z","timestamp":1787018887350,"version":"build-2736575974"},"reference-count":40,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402525"],"award-info":[{"award-number":["82402525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Intensive Care Med"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Septic patients with coronary artery disease (CAD) face elevated mortality risks, potentially exacerbated by glycemic variability (GV). This study aimed to investigate the association between GV and in-hospital and 1-year mortality in septic patients with CAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis using data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database as the discovery cohort and the Tianjin Health and Medical Database Platform (THMDP) as the validation cohort. Patients with sepsis and CAD who had at least three blood glucose measurements during their ICU stay were included. Glycemic variability was defined as the coefficient of variation of blood glucose levels, categorized into quartiles (Q1\u2013Q4). The primary outcome was in-hospital mortality, with 1-year mortality as a secondary outcome. Cox proportional hazards models were used to assess the association between GV and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Higher GV was significantly associated with increased in-hospital mortality in both cohorts (MIMIC-IV: n\u2009=\u20092599) adjusted Hazard Ratio (HR) 4.06, 95% CI 1.72-9.58,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.001; THMDP: n\u2009=\u20092,797, adjusted HR 1.56, 95% CI 1.25-1.93,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.001). A pooled two-cohort analysis confirmed a significant association with in-hospital mortality (adjusted HR for Q4 vs Q1: 1.65, 95% CI 1.34-2.03,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.001), while the association with 1-year mortality was weaker (adjusted HR 1.24, 95% CI 0.89-1.73,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.204). Restricted cubic spline (RCS) analyses revealed a nonlinear relationship between GV and in-hospital mortality (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for nonlinearity\u2009&lt;\u20090.001). Kaplan-Meier (KM) survival curves showed reduced survival probability in the highest GV group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Higher GV is independently associated with increased in-hospital mortality among septic patients with CAD, but no significant association was found with 1-year mortality. These findings suggest that stabilizing GV may be a critical area for clinical management and warrants further investigation. Monitoring and managing GV may improve outcomes in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/08850666251384922","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:33:53Z","timestamp":1763660033000},"page":"591-599","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Glycemic Variability with Mortality among Septic Patients with Coronary Artery Disease: A Multicenter Cohort Study"],"prefix":"10.1177","volume":"41","author":[{"given":"Hongda","family":"Hou","sequence":"first","affiliation":[{"name":"The Second Hospital of Tianjin Medical University"},{"name":"The Second Hospital of Tianjin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Guo","sequence":"additional","affiliation":[{"name":"Edith Cowan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Tianjin Medical University"},{"name":"The Second Hospital of Tianjin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxuan","family":"Han","sequence":"additional","affiliation":[{"name":"The Second Hospital of Tianjin Medical University"},{"name":"The Second Hospital of Tianjin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huachen","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second Hospital of Tianjin Medical University"},{"name":"The Second Hospital of Tianjin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2692-0595","authenticated-orcid":false,"given":"Bing","family":"Chen","sequence":"additional","affiliation":[{"name":"The Second Hospital of Tianjin Medical University"},{"name":"The Second Hospital of Tianjin Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001256"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aep339"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.01.038"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32989-7"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/epidemiologia5030032"},{"issue":"11","key":"e_1_3_4_7_2","first-page":"1271","article-title":"Individualised versus conventional glucose control in critically-ill patients: The CONTROLING study-a randomized clinical trial","volume":"47","author":"Boh\u00e9 J","year":"2021","unstructured":"Boh\u00e9 J, Abidi H, Brunot V, et al. Individualised versus conventional glucose control in critically-ill patients: The CONTROLING study-a randomized clinical trial. Intensive Care Med. 2021;47(11):1271\u20131283.","journal-title":"Intensive Care Med."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02693-0"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01931-3"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02048-3"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30136-0"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02241-0"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/19322968221146808"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2024.03.037"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/DMSO.S495930","article-title":"Effect of imeglimin, a novel anti-diabetic agent, on insulin secretion and glycemic variability in type 2 diabetes treated with DPP-4 inhibitor: A 16-week, open label, pilot study","volume":"18","author":"Itsukaichi A","year":"2025","unstructured":"Itsukaichi A, Yoshikawa F, Fuchigami A, et al. Effect of imeglimin, a novel anti-diabetic agent, on insulin secretion and glycemic variability in type 2 diabetes treated with DPP-4 inhibitor: A 16-week, open label, pilot study. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy. 2025;18:101\u2013111.","journal-title":"Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01580-4"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae715"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70057"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02238-7"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0063"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8138"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25147770"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.857368"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02048-3"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01861-0"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02146-w"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30696-2"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2047"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.11.3129"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.5.1650-a"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02265-4"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(03)00057-X"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2010.03.028"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.12.015"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05516-w"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112009"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2147\/DMSO.S479077","article-title":"Targeting the epigenetic marks in type 2 diabetes Mellitus: Will epigenetic therapy be a valuable adjunct to pharmacotherapy? Diabetes","volume":"17","author":"Odimegwu CL","year":"2024","unstructured":"Odimegwu CL, Uwaezuoke SN, Chikani UN, et al. Targeting the epigenetic marks in type 2 diabetes Mellitus: Will epigenetic therapy be a valuable adjunct to pharmacotherapy? Diabetes. Metabolic Syndrome and Obesity : Targets and Therapy. 2024;17:3557\u20133576.","journal-title":"Metabolic Syndrome and Obesity : Targets and Therapy"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31126-5"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577446"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07208-3"},{"issue":"3","key":"e_1_3_4_41_2","first-page":"28","article-title":"Impact of acute kidney injury on outcomes of hospitalizations for heat stroke in the United States","volume":"8","author":"Thongprayoon C","year":"2020","unstructured":"Thongprayoon C, Qureshi F, Petnak T, et al. Impact of acute kidney injury on outcomes of hospitalizations for heat stroke in the United States. Diseases (Basel, Switzerland). 2020;8(3):28.","journal-title":"Diseases (Basel, Switzerland)"}],"container-title":["Journal of Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666251384922","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08850666251384922","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08850666251384922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:46:21Z","timestamp":1780094781000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08850666251384922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1177\/08850666251384922"],"URL":"https:\/\/doi.org\/10.1177\/08850666251384922","relation":{},"ISSN":["0885-0666","1525-1489"],"issn-type":[{"value":"0885-0666","type":"print"},{"value":"1525-1489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}